![Lisa Rojkjaer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lisa Rojkjaer
Direttore Tecnico/Scientifico/R&S presso RIGEL PHARMACEUTICALS, INC.
Posizioni attive di Lisa Rojkjaer
Società | Posizione | Inizio | Fine |
---|---|---|---|
RIGEL PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 12/03/2024 | - |
Storia della carriera di Lisa Rojkjaer
Precedenti posizioni note di Lisa Rojkjaer
Società | Posizione | Inizio | Fine |
---|---|---|---|
VIRACTA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2020 | 05/05/2023 |
THOR MEDICAL | Direttore Tecnico/Scientifico/R&S | 15/11/2016 | 01/04/2020 |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/10/2013 | 01/11/2016 |
SANGAMO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 16/05/2023 | - |
Viracta Subsidiary, Inc.
![]() Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Direttore Tecnico/Scientifico/R&S | 01/05/2020 | - |
VIRACTA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 24/02/2021 | - |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - | - |
MORPHOSYS AG | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Lisa Rojkjaer
University of Toronto | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Svizzera | 3 |
Canada | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 7 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Settori
Health Technology | 12 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
MOLECULAR PARTNERS AG | Health Technology |
MORPHOSYS AG | Health Technology |
VIRACTA THERAPEUTICS, INC. | Health Technology |
SANGAMO THERAPEUTICS, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Sunesis Pharmaceuticals, Inc.
![]() Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Viracta Subsidiary, Inc.
![]() Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Borsa valori
- Insiders
- Lisa Rojkjaer
- Esperienza